These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26968716)
1. Predictors of survival for patients with cancer after cryptogenic stroke. Shin YW; Lee ST; Jung KH; Kim DY; Park CK; Kim TM; Choi SH; Chu K; Lee SK J Neurooncol; 2016 Jun; 128(2):277-84. PubMed ID: 26968716 [TBL] [Abstract][Full Text] [Related]
2. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke. Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388 [TBL] [Abstract][Full Text] [Related]
3. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249 [TBL] [Abstract][Full Text] [Related]
4. Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients. Nezu T; Kitano T; Kubo S; Uemura J; Yamashita S; Iwanaga T; Inoue T; Hosomi N; Maruyama H; Matsumoto M; Kimura K; Yagita Y J Neurol; 2018 Mar; 265(3):628-636. PubMed ID: 29372390 [TBL] [Abstract][Full Text] [Related]
5. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer. Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716 [TBL] [Abstract][Full Text] [Related]
8. Predictive impact of daily physical activity on new vascular events in patients with mild ischemic stroke. Kono Y; Kawajiri H; Kamisaka K; Kamiya K; Akao K; Asai C; Inuzuka K; Yamada S Int J Stroke; 2015 Feb; 10(2):219-23. PubMed ID: 25381835 [TBL] [Abstract][Full Text] [Related]
9. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Koton S; Tanne D; Green MS; Bornstein NM Neuroepidemiology; 2010; 34(2):90-6. PubMed ID: 20016218 [TBL] [Abstract][Full Text] [Related]
10. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP; Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117 [TBL] [Abstract][Full Text] [Related]
11. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke. Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile. Vallejos J; Jaramillo A; Reyes A; Illanes S; Orellana P; Manterola J; Díaz V J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):621-8. PubMed ID: 21602057 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Survival in Patients With Ischemic Stroke and Active Cancer: A Prospective, Multicenter, Observational Study. Gon Y; Sakaguchi M; Yamagami H; Abe S; Hashimoto H; Ohara N; Takahashi D; Abe Y; Takahashi T; Kitano T; Okazaki S; Todo K; Sasaki T; Hattori S; Mochizuki H; J Am Heart Assoc; 2023 Aug; 12(15):e029618. PubMed ID: 37489755 [TBL] [Abstract][Full Text] [Related]
14. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke. D'Amelio M; Terruso V; Famoso G; Di Benedetto N; Realmuto S; Valentino F; Ragonese P; Savettieri G; Aridon P J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):649-54. PubMed ID: 23834850 [TBL] [Abstract][Full Text] [Related]
15. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke. Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909 [TBL] [Abstract][Full Text] [Related]
16. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern. Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome, Its Components, and Diabetes on 5-Year Risk of Recurrent Stroke among Mild-to-Moderate Ischemic Stroke Survivors: A Multiclinic Registry Study. Fang X; Liu H; Zhang X; Zhang H; Qin X; Ji X J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):626-34. PubMed ID: 26725129 [TBL] [Abstract][Full Text] [Related]
18. The Impacts of Peptic Ulcer on Stroke Recurrence. Xu Z; Wang L; Lin Y; Wang Z; Zhang Y; Li J; Li S; Ye Z; Yuan K; Shan W; Liu X; Fan X; Xu G J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2106-2111. PubMed ID: 29653802 [TBL] [Abstract][Full Text] [Related]
19. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Kim SG; Hong JM; Kim HY; Lee J; Chung PW; Park KY; Kim GM; Lee KH; Chung CS; Bang OY Stroke; 2010 Apr; 41(4):798-801. PubMed ID: 20150545 [TBL] [Abstract][Full Text] [Related]
20. Short-term or long-term outcomes for stroke patients with cancer according to biological markers. Nezu T; Hosomi N; Aoki S; Naito H; Torii T; Kurashige T; Sugiura T; Kuzume D; Morimoto Y; Yoshida T; Yagita Y; Oyama N; Eto F; Shiga Y; Kinoshita N; Kamimura T; Ueno H; Ohshita T; Maruyama H J Neurol Sci; 2022 May; 436():120246. PubMed ID: 35405619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]